glp-1 obesity drug news october 21 2025 Are you eligible? Medicare's new Bridge program will cover certain weight-loss drugs starting this week. But as of now, the program isn't permanent: http://www.wltx.com/article/news/nation-world/medicare-covering-glp-1- weight-loss-drugs-bridge GLP-1 Agonists Market Report 2025-2033,

Description

Supplemental Material This article contains supplemental material located online at Supplementary Material Acknowledgments The authors thank Dr Timothy Ryder from Biological Communications Limited (London, United Kingdom) for writing and editorial assistance, funded by Allergan Aesthetics, an AbbVie company

These medications mimic that hormone to target areas of the brain that regulate appetite

Gastrointestinal tolerance to GLP-1s appears to vary among individuals, with some people experiencing fewer side effects than others

Spacing food out into four to six smaller meals instead of three large ones helps reduce that burden and keeps digestion moving more comfortably

Careful consideration of patient selection criteria and possible side effects, such as gastrointestinal discomfort and hypoglycemia, will be important when using GLP-1RAs for the treatment of IIH